Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial

Objectives SARS-Cov-2 virus preferentially binds to the Angiotensin Converting Enzyme 2 (ACE2) on alveolar epithelial type II cells, initiating an inflammatory response and tissue damage which may impair surfactant synthesis contributing to alveolar collapse, worsening hypoxia and leading to respira...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current controlled trials in cardiovascular medicine Jg. 21; H. 1; S. 1014 - 3
Hauptverfasser: Dushianthan, Ahilanandan, Clark, Howard, Madsen, Jens, Mogg, Robin, Matthews, Lewis, Berry, Lee, de la Serna, Jorge Bernardino, Batchelor, James, Brealey, David, Hussell, Tracy, Porter, Joanna, Djukanovic, Ratko, Feelisch, Martin, Postle, Anthony, Grocott, Michael P. W.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London BioMed Central 10.12.2020
BioMed Central Ltd
Springer Nature B.V
BMC
Schlagworte:
ISSN:1745-6215, 1745-6215
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!